Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community Read more about Section 50 of the Inflation Reduction Act Drug Price Negotiation Program: Considerations for the Centers for Medicare Medicaid Services, Manufacturers, and the Health Economics and Outcomes Research Community
How the Inflation Reduction Act Could Delay Pharmaceutical Launches, Reduce Indications, and Chill Evidence Generation Read more about How the Inflation Reduction Act Could Delay Pharmaceutical Launches, Reduce Indications, and Chill Evidence Generation
Oncology Drug Development: A Drug-Level Analysis of Subsequent Indications Read more about Oncology Drug Development: A Drug-Level Analysis of Subsequent Indications
NPC Submits Comments to CMS on Medicaid Drug Rebate Program Read more about NPC Submits Comments to CMS on Medicaid Drug Rebate Program
NPC Comments on CMS' Drug Price Negotiation Counteroffer Information Collection Request Read more about NPC Comments on CMS' Drug Price Negotiation Counteroffer Information Collection Request
NPC Comments on CMS Information Collection Request for Negotiation Data Elements Read more about NPC Comments on CMS Information Collection Request for Negotiation Data Elements
NPC Comments on CMS Medicare Drug Price Negotiation Program Read more about NPC Comments on CMS Medicare Drug Price Negotiation Program
Affordability Is About More Than Drug Prices Read more about Affordability Is About More Than Drug Prices
How Can We Address Barriers to Accessing Needed Care? Read more about How Can We Address Barriers to Accessing Needed Care?
Breaking Down Regulatory Barriers to Value Pricing for Prescription Drugs Read more about Breaking Down Regulatory Barriers to Value Pricing for Prescription Drugs